- Home
- TGLS vs CMPS Comparison
TGLS vs CMPS Comparison
Compare TGLS & CMPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TGLS | CMPS |
|---|---|---|
| Founded | 1984 | 2020 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Electronic Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.6B |
| IPO Year | 2011 | 2020 |
Fundamental Metrics
Financial Performance| Metric | TGLS | CMPS |
|---|---|---|
| Price | $46.64 | $8.96 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 16 |
| Target Price | ★ $57.25 | $23.31 |
| AVG Volume (30 Days) | 327.4K | ★ 3.3M |
| Earning Date | 11-05-2026 | 11-03-2026 |
| Dividend Yield | ★ 1.31% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.65 | N/A |
| Revenue | ★ $370,984,000.00 | N/A |
| Revenue This Year | $14.97 | N/A |
| Revenue Next Year | $12.20 | N/A |
| P/E Ratio | $27.78 | ★ N/A |
| Revenue Growth | ★ 17.98 | N/A |
| 52 Week Low | $34.05 | $4.88 |
| 52 Week High | $54.85 | $15.87 |
Technical Indicators
Market Signals| Indicator | TGLS | CMPS |
|---|---|---|
| Relative Strength Index (RSI) | 66.47 | 37.75 |
| Support Level | $41.54 | $7.88 |
| Resistance Level | $47.37 | $15.11 |
| Average True Range (ATR) | 2.06 | 0.94 |
| MACD | 0.66 | -0.02 |
| Stochastic Oscillator | 83.78 | 29.23 |
Price Performance
Historical ComparisonAbout TGLS Tecnoglass Inc.
Tecnoglass Holdings Inc, formerly Tecnoglass Inc, is a manufacturer of hi-spec architectural glass and windows for residential and commercial construction industries, operating through its direct and indirect subsidiaries. Its product offerings include tempered glass, laminated glass, thermo-acoustic glass, sliding windows, projecting windows, guillotine windows, sliding doors, loating facades, automatic doors, bathroom dividers, and commercial display windows, among others. The company has one operating segment, Architectural Glass and Windows, which is also its reporting segment. Geographically, the company generates maximum revenue from its customers in the United States, followed by Colombia, Panama, and other regions.
About CMPS COMPASS Pathways Plc American Depository Shares
Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support. The company is conducting clinical trials to evaluate the safety and efficacy of this treatment in patients with treatment-resistant depression and other mental health disorders. The company operates in one operating segment.